These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1889912)

  • 21. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M; Chang S; Hellriegel ET
    Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of acipimox and of its N-deoxy metabolite following single and repeated oral administration to healthy volunteers.
    Efthymiopoulos C; Strolin Benedetti M; Poggesi I; Ruff F; Basileo G; Musatti L
    Therapie; 1993; 48(1):23-6. PubMed ID: 8356541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype.
    Carr K; Oates JA; Nies AS; Woosley RL
    Br J Clin Pharmacol; 1978 Nov; 6(5):421-7. PubMed ID: 728285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects.
    May DG; Porter JA; Uetrecht JP; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1990 Dec; 48(6):619-27. PubMed ID: 2249373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of effect of proguanil on the pharmacokinetics of dapsone in healthy volunteers.
    Edstein MD; Rieckmann KH
    Chemotherapy; 1993; 39(4):235-41. PubMed ID: 8325124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylator phenotyping: a comparison of the isoniazid and dapsone tests.
    Hanson A; Melander A; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1981; 20(3):233-4. PubMed ID: 7286042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rapid method for determination of acetylation phenotype using dapsone.
    Philip PA; Roberts MS; Rogers HJ
    Br J Clin Pharmacol; 1984 Apr; 17(4):465-9. PubMed ID: 6721993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylator phenotyping: the effect of ethanol on the dapsone test.
    Hutchings A; Monie RD; Spragg B; Routledge PA
    Br J Clin Pharmacol; 1984 Jul; 18(1):98-100. PubMed ID: 6743494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dapsone in saliva and plasma of man.
    Peters JH; Murray JF; Gordon GR; Gelber RH
    Pharmacology; 1981; 22(3):162-71. PubMed ID: 7208598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of age, sex and body weight on the dapsone acetylation phenotype.
    Philip PA; Gayed SL; Rogers HJ; Crome P
    Br J Clin Pharmacol; 1987 Jun; 23(6):709-13. PubMed ID: 3606931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics of dapsone after oral administration to healthy volunteers.
    Pieters FA; Zuidema J
    Br J Clin Pharmacol; 1986 Oct; 22(4):491-4. PubMed ID: 3768260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylator phenotype in relation to age and gender in the Baltimore Longitudinal Study of Aging.
    Korrapati MR; Sorkin JD; Andres R; Muller DC; Loi CM; Vesell ES; Vestal RE
    J Clin Pharmacol; 1997 Feb; 37(2):83-91. PubMed ID: 9055133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.
    Peters JH; Gordon GR; Karat AB
    Am J Trop Med Hyg; 1975 Jul; 24(4):641-8. PubMed ID: 1155699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The disposition of dapsone in cirrhosis.
    May DG; Arns PA; Richards WO; Porter J; Ryder D; Fleming CM; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1992 Jun; 51(6):689-700. PubMed ID: 1611807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the presence of trimethoprim in the rat.
    Coleman MD; Russell RM; Tingle MD; Park BK
    J Pharm Pharmacol; 1992 Feb; 44(2):114-8. PubMed ID: 1352810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacokinetics of dapsone.
    Zuidema J; Hilbers-Modderman ES; Merkus FW
    Clin Pharmacokinet; 1986; 11(4):299-315. PubMed ID: 3530584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylator phenotype in Iraqi patients with allergic contact dermatitis.
    Najim RA; Al-waizt M; Al-Razzuqi RA
    Ann Saudi Med; 2005; 25(6):473-6. PubMed ID: 16438456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous high performance liquid chromatographic determination of dapsone and monoacetyldapsone in human plasma and urine.
    Abuirjeie MA; Irshaid YM; al-Hadidi HF; Rawashdeh NM
    J Clin Pharm Ther; 1991 Aug; 16(4):247-55. PubMed ID: 1939403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-acetylation phenotyping with dapsone in a mainland Chinese population.
    Horai Y; Zhou HH; Zhang LM; Ishizaki T
    Br J Clin Pharmacol; 1988 Jan; 25(1):81-7. PubMed ID: 3370194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.